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Abstract
This study aimed to determine the prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) carriage among
patients newly admitted to rehabilitation centres. It is a prospective study examining MRSA carriage on admission to seven rehabilitation
wards in four countries. Risk factors for MRSA carriage were analysed using univariate and multivariate analyses. A total of 1204
patients were studied. Among them, 105 (8.7%) had a positive admission MRSA screening result. The MRSA carriers were more likely
to be male, to have had a recent stay in another long-term-care facility or >2 weeks acute-care hospital stay, history of colonization
with MRSA, reduced level of consciousness, peripheral vascular disease and pressure sores. In multivariable logistic regression male gen-
der (odds ratio (OR) 2.2, 95% conﬁdence interval (CI) 1.4–3.6, p 0.001), history of MRSA positivity (OR 6.8, 95% CI 3.8–12.3,
p <0.001), peripheral vascular disease (OR 2.5, 95% CI 1.2–5, p 0.013), recent stay in another long-term-care facility (OR 2.1, 95% CI
1.3–3.5, p 0.004), or long (>2 weeks) acute-care hospital stay (OR 1.9, 95% CI 1.2–3, p 0.004), remained signiﬁcant risk factors for
MRSA carriage. MRSA carriage is common on admission to rehabilitation centres but less so, than previously described in long-term-
care facilities. Male gender, history of MRSA positivity, previous hospitalization and peripheral vascular disease may predict MRSA car-
riage, and may serve as indicators for using pre-emptive infection control measures.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) was ﬁrst
described in the early 1960s, and since then these strains
have spread in acute-care hospitals worldwide causing a vari-
ety of clinical syndromes ranging in severity from simple to
life-threatening infections [1,2].
Although data regarding MRSA carriage in acute-care hos-
pitals are widely available, ﬁrm data regarding facilities for
long-term care, including rehabilitation centres, are sparse.
The amount of care provided in long-term-care facilities
(LTCFs) has dramatically increased in the last decade, making
the question of MRSA carriage in this setting important but
unanswered. Patient exchange between rehabilitation centres
and acute-care hospitals is common, so reciprocal effects
exist between these institutions, and LTCFs are being
increasingly recognized as having a pivotal role in the spread
of antibiotic resistance [3,4].
The LTCFs are heterogeneous, ranging from institutions
that provide chronic care for the sick and elderly to rehabili-
tation centres, which are more dynamic and which provide
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care to a large number of patients with different needs.
Patients in rehabilitation centres have multiple characteristics
that are often found among MRSA carriers; most patients
are admitted after a long and complicated hospital stay, they
often have suffered multiple trauma, may have invasive
devices, and in some cases have been treated with multiple
antibiotic agents [3,4]. Moreover, host-related factors such
as older age, poor functional status, mental impairment,
alterations in mobility or swallowing and urinary inconti-
nence, are especially associated with higher risk of develop-
ing infections [3,4].
High rates of MRSA carriage have been found in LTCFs,
ranging between 8.8% and 23% [5–11]. However, most of
these were single-centre studies [5–7,9–11] and were per-
formed in LTCFs other than rehabilitation centres (nursing
homes or veteran centres) [5–9]. Moreover, these were
point prevalence studies, and do not provide information on
carriage upon admission to these facilities [5–9].
Hence, the aim of the present study was to determine the
prevalence of and risk factors for MRSA carriage in a large
number of patients newly admitted to seven rehabilitation
wards in four different countries.
Methods
Settings
This study is part of the Mastering Hospital Antimicrobial
Resistance in Europe (MOSAR) study, a European Commis-
sion-funded trans-disciplinary network devoted to the com-
bat and control of antimicrobial resistance in bacteria. The
project focuses on endemic and epidemic nosocomial patho-
gens in high-risk medical units including intensive-care units,
and surgery and rehabilitation centres in countries with high
levels of resistance. Here we present a portion of the results
from MOSAR work package 5, examining resistance in reha-
bilitation centres.
The study was conducted at seven wards in four rehabili-
tation centres: Tel-Aviv, Israel (two geriatric rehabilitation
wards); Badalona, Spain, (a spinal cord injury rehabilitation
unit); Rome, Italy, (one neurological and one orthopaedic
rehabilitation unit); and Berck, France, (two neurological and
orthopaedic rehabilitation wards).
These wards have a total of 290 hospital beds: 203 for
neurological rehabilitation, 34 for orthopaedic rehabilitation
and one ward of 53 beds dedicated to both. The study
included adult patients newly admitted to the study wards
between October 2008 and March 2010 (for 10–12 months
in each centre).
Design
This was a prospective case–control study, examining risk
factors for carriage of MRSA on admission to a rehabilitation
centre. Cases were newly admitted patients who were found
to be MRSA carriers when screened upon admission, and
controls were those who were MRSA negative upon screen-
ing. Cultures were taken on admission from all patients
newly admitted to the rehabilitation wards during the study
period.
Data collection
For purposes of the study, the following data were recorded:
demographics—patient age and sex, medical history including
underlying conditions, previous hospital or other LTCF stay,
previous history of colonization or infection with MRSA, his-
tory of antibiotic treatment during the month before admis-
sion, comorbidities, dependence in activities of daily living,
cognitive function and the presence of medical devices.
Microbiological methods
To assess MRSA colonization, samples for MRSA culture
were obtained from all newly admitted patients within 24 h
of admission. A nasal swab (Copan Italia, Brescia, Italy) was
taken from the anterior nares of each patient. Microbiologi-
cal methods used were evaluated as previously described
[12]; brieﬂy, swabs were transferred to the laboratory and
were directly plated onto BBL CHROMagar MRSA II medium
(BD Diagnostics, Sparks, MD, USA). Plates were kept and
handled according to the manufacturer’s instructions. After
incubation for 24 h, plates were read. Suspected MRSA colo-
nization was recorded for samples from which mauve colo-
nies were observed. Further veriﬁcation for MRSA was
obtained by colony morphology and size on tryptic soy broth
5% blood agar plates and by slide agglutination (Prolex, Staph
Xtra Latex Kit; PRO-LAB Diagnostics, Richmond Hill, ON,
Canada) in combination with DNase detection (DNase
plates; Hy-Labs, Rehovot, Israel). Patients were recorded as
MRSA non-carriers if mauve colonies were not observed
after 24 h of incubation. All MRSA isolates recovered were
identiﬁed according to a unique patient code and stored at
)80C for further investigation. Quality control testing was
successfully performed on each lot of chromogenic medium
using the MRSA ATCC 43300 and MSSA ATCC 29213
strains.
Statistical analysis
Risk factors were analysed by comparing MRSA-positive
patients (cases) with MRSA-negative patients (controls). Data
were analysed using univariate analysis: continuous variables
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were compared between groups using an unpaired t-test
within each group. Categorical parameters were compared
by using the Pearson chi-square test and p values £0.05 were
considered indicative of a signiﬁcant difference between
groups. Multivariate analysis using logistic regression predic-
tion models was constructed using forward stepwise (P to
enter = 0.1, P to remain = 0.05) selection. Interaction terms
and confounding were examined. All data were analysed
using SPSS software package version 15.0 (SPSS, Chicago, IL,
USA).
Ethics
The study was approved by each local institutional ethics
review board.
Results
A total of 1204 patients met the initial study criteria and
were screened on admission. Among them 105 (8.7%) were
positive for MRSA and 1099 (91.3%) were negative. The pro-
portion of positive cultures on admission to the different
rehabilitation centres was as follows: France 14.6%, Spain
8.1%, Italy 7.3% and Israel 7.1%. The proportion of positive
cultures was signiﬁcantly higher in the French centre than in
the other three centres (p <0.001, OR 2.2; 95% CI 1.4–3.4).
There was no signiﬁcant difference in the proportion of posi-
tive MRSA screening results between the patients admitted
for neurological or orthopaedic rehabilitation (8.7% versus
6.7%, respectively, p 0.26).
Table 1 summarizes the characteristics and comorbidities
of the patients according to their MRSA carriage status at
admission. Patients with positive results were more likely to
be male, to have had a recent stay in another LTCF or a
long (>2 weeks) acute-care hospital stay and a history of col-
onization with MRSA.
Comorbidities and conditions that were found to be sig-
niﬁcantly more common in the MRSA group included
reduced level of consciousness at the time of admission as
well as peripheral vascular disease and pressure sores. Anti-
biotic treatment in the month before admission was not
associated with MRSA status on admission.
Variables that were signiﬁcantly different between the
groups were entered into the multivariable logistic regres-
sion model. In this model, male gender, history of coloniza-
tion with MRSA, peripheral vascular disease, recent stay in
another LTCF or long (>2 weeks) acute-care hospital stay
were found to be independently associated with MRSA
screening positivity on admission (Table 2). Centre effect
was examined by including it as a variable in the model and
was not found to be signiﬁcantly associated with MRSA sta-
tus on admission or to affect the model signiﬁcantly.
Although history of colonization with MRSA in the past
was found to be the strongest predictor for having a positive
MRSA screening result in a multivariable logistic regression
model (OR 6.8, Table 2), most patients with a past history
TABLE 1. Comparison of demographic characteristics and comorbidities in patients with positive and negative results on
methicillin-resistant Staphylococcus aureus screening
MRSA positive (n = 105) MRSA negative (n = 1099) p OR
Demographic parameters
Male: female (%) 69/31 45/55 <0.001 4
Age mean ± SD (year) 68.3 ± 19.8 69.3 ± 18.6 0.6
Age >65 years (n, %) 60 (57.1) 734 (66.8) 0.041 0.6
Admitted from acute-care facility (n, %) 91 (86.7) 955 (86.9) 0.99 1
Long acute-care hospital stay (>2 weeks) (n, %) 66 (62.9) 464 (42.2) <0.001 2.3
Recent stay in another long-term-care facility (n, %) 46 (43.8) 271 (24.7) <0.001 2.4
Comorbidities
History of colonization with MRSA (n, %) 28 (26.7) 45 (4.1) <0.001 8.5
History of colonization with multidrug resistance bacteria
other than MRSA (n, %)
1 (1) 31 (2.8) 0.4 0.4
Admitted with infection 11 (10.5) 126 (11.5) 0.76 0.9
Reduced level of consciousness (n, %) 25 (23.8) 152 (13.8) 0.006 1.9
Cardiovascular disease (n, %) 60 (57.1) 654 (59.5) 0.58 0.9
Peripheral vascular disease (n, %) 13 (12.4) 52 (4.7) 0.001 2.8
Pressure sores (n, %) 20 (19) 98 (8.9) 0.001 2.4
Diabetes mellitus (n, %) 24 (22.9) 237 (22) 0.78 1.1
Chronic lung disease (n, %) 14 (13.3) 99 (9) 0.15 1.5
Cerebral vascular accident/transient ischaemic attack (n, %) 20 (19) 171 (16) 0.36 1.3
Tetraplegia/Quadriplegia (n, %) 20 (19) 141 (12.8) 0.07 1.6
Dementia (n, %) 6 (5.7) 70 (6.4) 0.78 0.9
Renal disease (n, %) 16 (15.2) 106 (9.6) 0.07 1.7
Malignancy (n, %) 10 (9.5) 175 (15.9) 0.08 0.6
Immunodeﬁciency (n, %) 9 (8.6) 49 (4.5) 0.06 2
Surgery/Invasive procedure in last year (n, %) 72 (68.6) 665 (60.5) 0.12 1.4
Invasive device in the past month (n, %) 78 (74.3) 764 (69.5) 0.38 1.2
MRSA, methicillin-resistant Staphylococcus aureus; OR, odds ratio.
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of MRSA had a negative screening result on admission (45 of
73, 61.6%). To examine whether risk factors for MRSA posi-
tivity differed between patients without a history of MRSA
carriage, we performed a subgroup analysis for patients who
were not known to have been colonized with MRSA in the
past (n = 1026). In this group of patients the predictors for
positive MRSA screening were similar to those identiﬁed in
the entire study cohort, including male gender (OR 2.6, 95%
CI 1.5–4.3, p <0.001), peripheral vascular disease (OR 2.9,
95% CI 1.4–6.1, p 0.006), long (>2 weeks) acute-care hospi-
tal stay (OR 1.9, 95% CI 1.2–3.2, p 0.008) and recent stay in
another LTCF (OR 1.7, 95% CI 0.99–2.8, p 0.054).
We also examined the subgroup of patients who were
known to be colonized with MRSA in the past (n = 73).
Patients admitted with infection and those receiving antibi-
otic treatment on admission were more likely to have nega-
tive screening results for MRSA than their counterparts (33%
versus 11%, p 0.03, and 45% versus 14%, p 0.009, respec-
tively). The types of infection in the subgroup of patients
with a history of MRSA and a negative admission screen
included urinary tract infection (n = 6), skin infection (n = 5),
pneumonia (n = 2) and bacteraemia (n = 2).
Discussion
This multicentre, multinational large prospective study pro-
vides data on the prevalence of and risk factors for MRSA
colonization on admission to rehabilitation centres. Our two
main ﬁndings are a lower than expected MRSA colonization
prevalence on admission and a description of the proﬁle of
MRSA carriers.
Previous studies were conducted in various types of
LTCFs, and found the MRSA colonization prevalence to
range from 8.8% to 23% [5–11]. In contrast, in this study we
found a lower mean MRSA carriage prevalence of 8.7%, and
in three of the four centres the prevalence was lower than
the lowest previously reported. There are several possible
explanations for this ﬁnding. First, our study was conducted
in rehabilitation centres and most other studies were con-
ducted in other types of LTCFs. Indeed, in previous reports
from rehabilitation centres, prevalence was relatively low
(12–16.5%) compared with other LTCFs, but it was still
higher than the prevalence we found [9,10]. Second, a trend
is presently observed in most European countries of
decreasing rates of MRSA [13]. This decrease has been sug-
gested to be related to the improved quality of infection
control practices in medical centres, and to countrywide
efforts to limit the spread of MRSA [13], as well as other
factors. Interestingly, although according to the 2010 annual
report of the European Antimicrobial Resistance Surveillance
System (EARSS), France had a lower proportions of invasive
MRSA infection compared with Italy and Spain (21.6% versus
36.5% and 25.3%, respectively), in our study the French cen-
tre had a higher MRSA carriage prevalence than the centres
in Italy, Israel and Spain [13]. We believe that these varia-
tions in prevalence of MRSA colonization on admission to
the four rehabilitation centres participating in the MOSAR
study may reﬂect differences in prevalence of MRSA among
referring centres as well as differences in patient populations
referred to each of the centres [5–11]. Moreover, these
variations may be related to differences between patient
populations admitted to the four studied rehabilitation cen-
tres.
A third explanation for the lower than expected MRSA
carriage prevalence in our study may relate to study design.
Most previous studies in LTCFs were point prevalence stud-
ies, so most patients studied already had prolonged LTCF
stay [5–9]; whereas our study included only newly admitted
patients. This last explanation may have important ramiﬁca-
tions: if indeed rates of MRSA carriage on admission to
LTCFs are much lower than during a prolonged stay, then
LTCFs are likely to be a signiﬁcant hub for transmission and
ampliﬁcation of MRSA. This ﬁnding requires further conﬁr-
mation from longitudinal studies analysing acquisition events,
and if found correct, should be followed by interventions to
reduce transmission.
The proﬁle of MRSA carriers in our study reﬂects several
domains. Risk for being a carrier on admission is higher with
longer and more extensive contact with the healthcare set-
ting (as reﬂected by longer stay in the acute-care setting and
past stay in an LTCF). This ﬁnding has been described previ-
ously in multiple studies in various settings, and reﬂects the
increased likelihood of MRSA acquisition in healthcare set-
tings [6,8–10]. Another variable associated with a positive
screening result on admission was a history of being an
MRSA carrier. Indeed, carriage of MRSA may extend for
periods of over 5 years, so even a remote history of MRSA
TABLE 2. Multivariable logistic regression model demon-
strating variables associated with methicillin-resistant Staph-
ylococcus aureus colonization
OR 95% CI p
Gender (male) 2.2 1.4–3.6 0.001
History of colonization with MRSA 6.8 3.8–12.3 <0.001
Peripheral vascular disease 2.5 1.2–5 0.013
Long acute-care hospital stay (>2 weeks) 1.9 1.2–3 0.004
Recent stay in another long-term-care facility 2.1 1.3–3.5 0.004
95% CI, 95% conﬁdence interval; MRSA, methicillin-resistant Staphylococcus aur-
eus; OR, odds ratio.
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positivity should be considered a strong predictor, as found
in our study. Interestingly, we found that 61.6% of those with
a history of colonization had a negative screening result on
admission. These patients had signiﬁcantly higher rates of
intercurrent infection on admission and treatment with an
antibiotic (although mostly without MRSA coverage). This
ﬁnding cannot be explained by direct activity of the antibiotic
on suppressing MRSA, and may reﬂect an indirect effect on
MRSA by changes in the nasopharyngeal microﬂora, which in
turn may affect MRSA carriage. We believe that this ﬁnding
deserves to be further studied. Male gender was found to be
a risk factor, by us as well as in other studies [6,8]. Previous
studies explained the male predominance among MRSA carri-
ers by the fact that other risk factors for MRSA colonization
are more prevalent among men than women [14].
The only comorbid condition found in our study to be
associated with MRSA carriage was peripheral vascular dis-
ease. This association has not been described previously in
the setting of LTCFs. We hypothesize that the association
may reﬂect previous hospitalization in wards with a high
prevalence of MRSA. In addition, the presence of non-intact
skin as the result of peripheral vascular disease may promote
colonization with MRSA.
Our study has several limitations. First, the rehabilitation
wards that were studied are heterogeneous, representing
various patient populations with differing indications for
rehabilitation and different acute-care settings of origin. This
variety may have reduced our ability to identify some impor-
tant risk factors, which might have been detected had we
studied a more homogeneous population. This limitation is
offset by the greater generalizability deriving from studying a
heterogeneous population. Second, our study used conven-
tional culture not supplemented by molecular techniques to
improve detection of MRSA carriage. This may have led to
some misclassiﬁcation of carriers as non-carriers. However,
a recent study suggests that this misclassiﬁcation may not
occur frequently [15]. Moreover, if such misclassiﬁcation did
occur it would bias our results towards the null, thereby not
diminishing the strength of our positive ﬁndings. Another
potential limitation for our study regards the microbiological
methods we used to detect MRSA carriers; ﬁrst, only nasal
swabs were screened while additional samples including
throat, perineum and decubitus ulcers could potentially
increase the sensitivity of the screening. Second, some
authors suggest enrichment and prolonged incubation time
of the screening agar to increase the recovery rate and raise
the sensitivity of the screening. However, a recent study
regarding this speciﬁc point did ﬁnd excellent speciﬁcity of
this more rapid method [16]. Nevertheless, we might have
missed some newly admitted patients with very low coloniza-
tion loads.
In summary, we found that MRSA colonization on admis-
sion to European rehabilitation centres is less common than
expected. The discrepancy relative to the higher proportions
of carriers found in previous point prevalence studies in
LTCFs may reﬂect high intra-rehabilitation centre transmis-
sion and ampliﬁcation of MRSA. We identiﬁed concurrent
antibiotic treatment as a negative predictor of MRSA screen
positivity among past carriers, which may suggest a reduction
in the ability to detect carriage if screening is performed
while receiving antibiotic treatment. As data regarding the
speciﬁc consequences of MRSA colonization on patients in
rehabilitation centres are lacking, and to better understand
the epidemiology of MRSA in rehabilitation centres, further
studies, including longitudinal studies, are required.
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